Investigating how xylazine affects skin health and blood flow
Official title: Molecular pharmacology of xylazine at adrenoceptors: Relation to necrotic skin lesions associated with chronic intravenous administration
Funded at Mercer University Macon · NIH-10951109 · Data updated 2026-11-12
This study is looking into how the drug xylazine, often used for animals, can harm people by causing serious skin problems when misused, especially for those who also use opioids, and it aims to understand how it affects blood flow and oxygen to the skin.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Mercer University Macon NIH-funded |
| Lab location | 1 site (Macon, United States) |
| Project start | September 15, 2024 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $387,750 |
| NIH project number | 1R21DA061097-01 |
| Project ID | NIH-10951109 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults over 21 who have experienced skin issues related to xylazine or opioid use.
✕Less likely to help
Patients who have not used xylazine or are not affected by skin lesions related to its use may not benefit from this research.
What this research studies
This research focuses on understanding the effects of xylazine, a drug commonly used in veterinary medicine, on human health, particularly its role in causing severe skin lesions when used illicitly. The study will explore how xylazine interacts with specific receptors in the body, which may lead to reduced blood flow and oxygen supply to the skin, resulting in necrosis. By examining these mechanisms, the research aims to provide insights into the adverse effects associated with xylazine use, especially in individuals who misuse opioids. The approach includes laboratory experiments to analyze receptor interactions and their consequences on skin health.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and treatment options for skin lesions caused by xylazine use.
How similar studies have gone: While the specific mechanisms of xylazine's effects are not well-studied, similar research on other drugs affecting blood flow and skin health has shown promising results.
Where this research is happening
-
Mercer University Macon
Macon, United States Active
Researchers
- Principal investigator: Canal, Clinton E — Mercer University Macon
- Study coordinator: Canal, Clinton E
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.